MaxCyte Inc (NASDAQ:MXCT) shares, rose in value on Thursday, April 16, with the stock price up by 2.35% to the previous day’s close as strong demand from buyers drove the stock to $2.61.
Actively observing the price movement in the last trading, the stock closed the session at $2.55, falling within a range of $2.525 and $2.63. The value of beta (5-year monthly) was 1.214. Referring to stock’s 52-week performance, its high was $5.26, and the low was $2.21. On the whole, MXCT has fluctuated by -20.18% over the past month.
With the market capitalization of MaxCyte Inc currently standing at about $276.73 million, investors are eagerly awaiting this quarter’s results, scheduled for on 2025-Mar-10.
Projections by analysts suggest varying estimates for the company’s quarterly revenue. Analysts have estimated the company’s revenue for the quarter at 41.38M, with a low estimate of 7.78M and a high estimate of 9.9M. Wall Street analysts also predicted that the company’s y-o-y revenues would reach 9.05M.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that MXCT’s technical picture suggests that short-term indicators denote the stock is a 100% Sell on average. However, medium-term indicators have put the stock in the category of 100% Sell while long-term indicators on average have been pointing out that it is a 100% Sell.
The stock’s technical analysis shows that the price of MXCT currently trading nearly -2.58% and -20.18% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 41.72, while the 7-day volatility ratio is showing 10.23% which for the 30-day chart, stands at 8.55%. Furthermore, MaxCyte Inc (MXCT)’s average true range (ATR) is 0.23.
A comparison of MaxCyte Inc (MXCT) with its peers suggests the former has fared considerably weaker in the market. MXCT showed an intraday change of 2.35% in last session, and over the past year, it shrunk by -34.59%%.
Data on historical trading for MaxCyte Inc (NASDAQ:MXCT) indicates that the trading volumes over the past 10 days have averaged 0.77 and over the past 3 months, they’ve averaged 637.87K. According to company’s latest data on outstanding shares, there are 105.71 million shares outstanding.
Nearly 7.87% of MaxCyte Inc’s shares belong to company insiders and institutional investors own 71.48% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 3.29 million shares as on 2025-03-31, resulting in a short ratio of 4.46. According to the data, the short interest in MaxCyte Inc (MXCT) stood at 313.00 of shares outstanding as of 2025-03-31; the number of short shares registered in 2025-02-28 reached 2.7 million. The stock has fallen by -37.26% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the MXCT stock heading into the next quarter.
